Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin M Wright

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Health Data Science|May 6, 2026
Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry DataJianrong Zhang, Maarten J IJzerman, Damien McCarthy, et al.
Clinical Lung Cancer|June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung CancerJose Luis Leal, Marliese Alexander, Malinda Itchins, et al.
The Annals of Thoracic Surgery|August 28, 2022
Use of Indocyanine Green Fluorescence Imaging in Thoracic and Esophageal SurgeryCalvin Sze-Hang Ng, Boon-Hean Ong, Yin Kai Chao, et al.
Nature Communications|September 15, 2019
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinomaSarah A Best, Sheryl Ding, Ariena Kersbergen, et al.
Respirology (Carlton, Vic.)|August 13, 2024
Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancerJessica Nash, Emily Stone, Shalini Vinod, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Future Oncology (London, England)|May 8, 2020
Tubeless video-assisted thoracic surgery for lung cancer: is it ready for prime time?Yaokai Wen, Yu Jiang, Hengrui Liang, et al.
Molecular Cancer Therapeutics|June 15, 2017
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell CarcinomaClare E Weeden, Aliaksei Z Holik, Richard J Young, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Health Data Science|May 6, 2026
Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry DataJianrong Zhang, Maarten J IJzerman, Damien McCarthy, et al.
Clinical Lung Cancer|June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung CancerJose Luis Leal, Marliese Alexander, Malinda Itchins, et al.
The Annals of Thoracic Surgery|August 28, 2022
Use of Indocyanine Green Fluorescence Imaging in Thoracic and Esophageal SurgeryCalvin Sze-Hang Ng, Boon-Hean Ong, Yin Kai Chao, et al.
Nature Communications|September 15, 2019
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinomaSarah A Best, Sheryl Ding, Ariena Kersbergen, et al.
Respirology (Carlton, Vic.)|August 13, 2024
Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancerJessica Nash, Emily Stone, Shalini Vinod, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Future Oncology (London, England)|May 8, 2020
Tubeless video-assisted thoracic surgery for lung cancer: is it ready for prime time?Yaokai Wen, Yu Jiang, Hengrui Liang, et al.
Molecular Cancer Therapeutics|June 15, 2017
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell CarcinomaClare E Weeden, Aliaksei Z Holik, Richard J Young, et al.
Pageof 7